Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Long-term Potentiation01:35

Long-term Potentiation

59.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
59.2K
Long-term Potentiation01:25

Long-term Potentiation

3.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Securing our HIV response: The PEPFAR crisis in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Patch testing sodium tetrachloropalladate is a better means to detect palladium sensitisation then palladium chloride-Results of a clinical-epidemiological study of the Information Network of Departments of Dermatology (IVDK) from 2003 to 2022.

Contact dermatitis·2024
Same author

The gut microbiota in adults with cystic fibrosis compared to colorectal cancer.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
Same author

Electric Fields in Liquid Water Irradiated with Protons at Ultrahigh Dose Rates.

Physical review letters·2023
Same author

Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
Same author

Naringin prevents the reduction of the number of neurons and the volume of CA1 in a scopolamine-induced animal model of Alzheimer's disease (AD): a stereological study.

The International journal of neuroscience·2022

Related Experiment Video

Updated: Mar 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K

Levodopa medication improves incidental sequence learning in Parkinson's disease.

M Beigi1, L Wilkinson2, F Gobet3

  • 1Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Division of Psychology, Department of Life Sciences, Brunel University, Uxbridge UB8 3PH, UK.

Neuropsychologia
|November 7, 2016
PubMed
Summary

Levodopa medication improved incidental sequence learning in Parkinson's disease (PD) patients, even when they were unaware of the sequence. This suggests dopamine's role in learning motor sequences in early PD.

Keywords:
Basal gangliaIncidental sequence learningLevodopa medicationParkinson's diseaseSerial reaction timeStriatum

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

27.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

27.0K

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Pharmacology

Background:

  • Levodopa is a primary treatment for Parkinson's disease (PD) motor symptoms.
  • Its effect on cognitive processes, particularly learning, is debated, with the 'dopamine overdose' hypothesis suggesting impairment.
  • Incidental sequence learning is known to be impaired in PD, but the impact of dopaminergic therapy was unclear.

Purpose of the Study:

  • To investigate the effect of dopaminergic medication (levodopa) on incidental sequence learning in Parkinson's disease patients.
  • To determine if levodopa enhances or impairs incidental learning in PD using a probabilistic sequence task.

Main Methods:

  • A probabilistic serial reaction time task (SRTT) was used to assess incidental sequence learning.
  • The same group of 15 PD patients was tested in two conditions: 'on' levodopa medication and 'off' medication after overnight withdrawal.
  • Performance was compared between the 'on' and 'off' states within the patient group and against a healthy control group.

Main Results:

  • Levodopa medication significantly enhanced incidental learning of a probabilistic sequence in PD patients.
  • Patients learned the sequence incidentally, without conscious awareness of its existence or their learning.
  • No significant difference was found between PD patients (on or off medication) and the healthy control group, highlighting the importance of within-group comparisons.

Conclusions:

  • Levodopa medication enhances incidental motor sequence learning in Parkinson's disease.
  • The findings support a role for the dorsal striatum, which is affected by dopamine depletion in early PD, in acquiring incidental sequence learning.
  • Within-group comparisons are crucial for detecting subtle cognitive effects of dopaminergic medication in PD.